Curious to see your top suppliers emissions?
Book a demo for a pilot project
Sino Biopharmaceutical
Pharmaceutical Preparation ManufacturingHong Kong SAR ChinaPNK: SBMFF
Last verified 28 days agocttq-europe.com
Sino Biopharmaceutical Limited, commonly referred to as Sino Biopharmaceutical, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Hong Kong. Established in 1996, the company has made significant strides in developing innovative medicines, particularly in the fields of oncology, cardiovascular, and central nervous system disorders.
With a robust presence in major operational regions across China and expanding internationally, Sino Biopharmaceutical is renowned for its commitment to research and development. The company’s core products include a diverse range of prescription medications and therapeutic solutions, distinguished by their high quality and efficacy.
Sino Biopharmaceutical has achieved notable market recognition, positioning itself among the top pharmaceutical manufacturers in China, and continues to drive advancements in healthcare through its dedication to innovation and excellence.
33
DitchCarbon score
-9 vs industry average
Sino Biopharmaceutical’s score of 33 is lower than 46% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sino Biopharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Sino Biopharmaceutical's reported carbon emissions
As a pharmaceutical preparation manufacturer headquartered in Hong Kong, Sino Biopharmaceutical reported total Scope 1 and 2 carbon emissions of approximately 208.2 million kg CO2e in 2024. This comprised around 18.2 million kg CO2e from Scope 1 emissions and approximately 190.0 million kg CO2e from Scope 2 emissions. This figure represents a reduction from 2023, when total Scope 1 and 2 emissions were about 239.2 million kg CO2e (approximately 17.0 million kg CO2e from Scope 1 and 222.2 million kg CO2e from Scope 2).
Sino Biopharmaceutical has a near-term intensity target to reduce greenhouse gas emissions per RMB 1 million of revenue by 20% by 2025, using 2021 as the benchmark year. In 2021, the company's Scope 1 emissions were approximately 21.7 million kg CO2e, and Scope 2 emissions were about 253.2 million kg CO2e. The company does not currently disclose Scope 3 emissions data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sino Biopharmaceutical’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Sino Biopharmaceutical28 days ago
33
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more